These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37916797)

  • 21. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
    Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
    Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study.
    van de Vlasakker VCJ; van Erning FN; Lurvink RJ; de Hingh IHJT; Nienhuijs SW
    World J Surg Oncol; 2023 Oct; 21(1):328. PubMed ID: 37845754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.
    Seyfried F; von Rahden BH; Miras AD; Gasser M; Maeder U; Kunzmann V; Germer CT; Pelz J; Kerscher AG
    BMC Cancer; 2015 Feb; 15():73. PubMed ID: 25879885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group.
    Kato M; Nishida T; Yamamoto K; Hayashi S; Kitamura S; Yabuta T; Yoshio T; Nakamura T; Komori M; Kawai N; Nishihara A; Nakanishi F; Nakahara M; Ogiyama H; Kinoshita K; Yamada T; Iijima H; Tsujii M; Takehara T
    Gut; 2013 Oct; 62(10):1425-32. PubMed ID: 22914298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Morita J; Segami K; Onodera A; Endo K; Onuma S; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(5):2514-2520. PubMed ID: 36099136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival.
    Rijken A; Lurvink RJ; Luyer MDP; Nieuwenhuijzen GAP; van Erning FN; van Sandick JW; de Hingh IHJT
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and risk factors of gastric cancer detected by esophagogastroduodenoscopy in esophageal cancer patients.
    Ito R; Kadota T; Murano T; Yoda Y; Hori K; Minamide T; Sato D; Yamamoto Y; Takashima K; Shinmura K; Ikematsu H; Yano T
    Esophagus; 2021 Jul; 18(3):621-628. PubMed ID: 33630192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
    Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection.
    Jang MY; Cho JW; Oh WG; Ko SJ; Han SH; Baek HK; Lee YJ; Kim JW; Jung GM; Cho YK
    Korean J Intern Med; 2013 Nov; 28(6):687-93. PubMed ID: 24307844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.
    Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study.
    Rijken A; van de Vlasakker VCJ; Simkens GA; Rovers KP; van Erning FN; Koopman M; Verhoef C; de Wilt JHW; de Hingh IHJT
    Clin Exp Metastasis; 2023 Aug; 40(4):289-298. PubMed ID: 37209222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods.
    Yarema R; Оhorchak М; Hyrya P; Kovalchuk Y; Safiyan V; Karelin I; Ferneza S; Fetsych M; Matusyak M; Oliynyk Y; Fetsych Т
    World J Gastrointest Oncol; 2020 May; 12(5):569-581. PubMed ID: 32461788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications.
    Tsoli M; Wilson H; Armonis P; Kamieniarz L; Thuringer J; Mirnezami R; Caplin M; Kaltsas G; Toumpanakis C
    J Endocrinol Invest; 2024 Sep; 47(9):2295-2303. PubMed ID: 38451399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous and metachronous cancers in patients with gastric cancer.
    Eom BW; Lee HJ; Yoo MW; Cho JJ; Kim WH; Yang HK; Lee KU
    J Surg Oncol; 2008 Aug; 98(2):106-10. PubMed ID: 18452218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database.
    Rijken A; Galanos LJK; Burger JWA; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):60-66. PubMed ID: 37359924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of metachronous gastric neoplasm after endoscopic resection in patients with synchronous gastric neoplasm.
    Shin GY; Cho HJ; Park JM; Lim CH; Cho YK; Choi MG
    BMC Gastroenterol; 2020 Jun; 20(1):206. PubMed ID: 32605537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.